We are live on !
Find out more
22NW LP Portfolio holdings
AUM
$105M
Turnover
23.53%
1-Year Est. Return
38.33%
This Fund
S&P 500
This Quarter Est. Return
+27.49%
1 Year Est. Return
+38.33%
3 Year Est. Return
+138.09%
5 Year Est. Return
+232.99%
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$41.2M
(-28%)
Cap. Flow
-$41.6M
Cap. Flow % of AUM
Cap. Flow %
-39.73%
Top 10 Holdings %
Top 10 Hldgs %
94.62%
Holding
17
New
1
Increased
1
Reduced
1
Closed
3
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Molding Technologies
CMT
|
+$1.25M |
| 2 |
Turtle Beach Corp
TBCH
|
+$171K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Foster
FSTR
|
+$29.8M |
| 2 |
Mineralys Therapeutics
MLYS
|
+$9.07M |
| 3 |
Farmer Brothers
FARM
|
+$2.48M |
| 4 |
PhenixFIN
PFX
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.6% |
| 2 | Healthcare | 33.8% |
| 3 | Industrials | 22.26% |
| 4 | Materials | 6.17% |
| 5 | Technology | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Insperity
NSP
$2.08B
| $20.4M | 19.45% |
493,000
| – | – |
2025 Q4
2 quarters
|
|
2
Nektar Therapeutics
NKTR
$1.27B
| $19.6M | 18.75% |
281,115
| – | – |
2024 Q4
6 quarters
|
|
3
Stoneridge
SRI
$167M
| $18.1M | 17.25% |
2,466,975
| – | – |
2024 Q4
6 quarters
|
|
4
Fox Factory Holding Corp
FOXF
$633M
| $11.5M | 10.98% |
678,165
| – | – |
2026 Q1
1 quarter
|
|
|
5
Core Molding Technologies
CMT
$205M
| $6.46M | 6.17% |
273,521
+50,783
| +23% | +$1.25M |
2025 Q2
4 quarters
|
|
6
Regenxbio
RGNX
$441M
| $5.9M | 5.64% |
492,759
| – | – |
2025 Q1
5 quarters
|
|
7
Culp Inc
CULP
$45.1M
| $5.76M | 5.51% |
1,859,061
| – | – |
2020 Q1
25 quarters
|
|
8
Rezolute
RZLT
$372M
| $4.27M | 4.08% |
820,653
| – | – |
2025 Q3
3 quarters
|
|
9
UNIFI
UFI
$102M
| $4.05M | 3.87% |
852,455
| – | – |
2024 Q4
6 quarters
|
|
|
10
Mineralys Therapeutics
MLYS
$1.82B
| $3.07M | 2.93% |
113,840
-330,485
| -74% | -$9.07M |
2025 Q1
5 quarters
|
|
11
Team
TISI
$111M
| $2.94M | 2.81% |
170,187
| – | – |
2025 Q1
5 quarters
|
|
12
Eledon Pharmaceuticals
ELDN
$187M
| $2.51M | 2.4% |
636,364
| – | – |
2025 Q1
5 quarters
|
|
|
13
Turtle Beach Corp
TBCH
$295M
| $180K | 0.17% |
+14,430
| New | +$171K |
2026 Q2
0 quarters
|
|
14
Lifecore Biomedical
LFCR
$243M
| $6.22K | 0.01% |
1,254
| – | – |
2021 Q2
20 quarters
|
|
|
15
DELISTED
Farmer Brothers
FARM
| – | – |
-1,955,526
| Closed | -$2.48M | – |
|
|
16
Foster
FSTR
$370M
| – | – |
-1,067,186
| Closed | -$29.8M | – |
|
|
17
PhenixFIN
PFX
$81.9M
| – | – |
-43,115
| Closed | -$1.68M | – |
|
Similar funds
TPW
22NW LP's Q2 2026 Portfolio in Review
As of Q2 2026, 22NW LP held 17 positions worth $105M, down 28% from $146M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
22NW LP withdrew a net $41.6M in Q2 2026, closing 3 positions and reducing 1 holding. Its most notable exit was Foster, an estimated $29.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 22NW LP opened a new position in Turtle Beach Corp worth $180K.
- 22NW LP's largest Q2 2026 buy was Turtle Beach Corp: 14,430 shares worth $180K.
- 22NW LP added most to Core Molding Technologies in Q2 2026, an estimated $1.25M increase.
- 22NW LP's biggest Q2 2026 reduction was Mineralys Therapeutics, cutting an estimated $9.07M.
- 22NW LP fully exited Foster in Q2 2026, selling an estimated $29.8M.
- 22NW LP's ten largest holdings make up 95% of its $105M portfolio in Q2 2026.
- 22NW LP opened 1 new position and closed 3 in Q2 2026.
- 22NW LP's portfolio value fell 28% quarter-over-quarter to $105M.
Based on 22NW LP's 13F filing for Q2 2026, filed 14 Aug 2026.